General MedicationsINHALATIONStandard

ALBUTEROL SULFATE; IPRATROPIUM BROMIDE

Standard Dose

0.5MG; 0.017%

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview ALBUTEROL SULFATE; IPRATROPIUM BROMIDE is listed in Drugs@FDA under application 076749 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ALBUTEROL SULFATE; IPRATROPIUM BROMIDE Form and strength SOLUTION; INHALATION - 0.5MG; 0.017% Sponsor NEPHRON Submission history Latest submission status date: 2012-08-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview ALBUTEROL SULFATE; IPRATROPIUM BROMIDE is listed in Drugs@FDA under application 076749 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ALBUTEROL SULFATE; IPRATROPIUM BROMIDE Form and strength SOLUTION; INHALATION - 0.5MG; 0.017% Sponsor NEPHRON Submission history Latest submission status date: 2012-08-13 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.